Home
Issues
Browse By Topic
Conference Correspondent
- ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
- ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Association for Value-Based Cancer Care
Value-Based Care in Myeloma

Andrew Stainthorpe, PhD

Authored Articles

Approaches to Alleviating Costs for Patients and Payers

Andrew Stainthorpe, PhD

Value-Based Concerns of European Oncologists

Andrew Stainthorpe, PhD

Keeping Cost Out of the Drug Approval Debate

Andrew Stainthorpe, PhD

Using Research to Guide Quality and Quantity of Care

Andrew Stainthorpe, PhD

Personalized Medicine

Bringing the Patient into the Conversation

Andrew Stainthorpe, PhD

Personalized Medicine

Weighing Cost and Care: An Oncologist’s Debate

Andrew Stainthorpe, PhD

Personalized Medicine

Benefits of the Single Payer Perspective

Andrew Stainthorpe, PhD

Top Trending Articles

1.

FDA Approves Acalabrutinib and Venetoclax Combination for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

2.

FDA Launches Unified Adverse Event Monitoring System to Enhance Transparency and Efficiency

3.

Financial Toxicity in Cancer Care: Why the Conversation Must Start Before Treatment Begins

Jan Hailey, MHL, CMC, CMCO, CMIS, CMOM, CMCA-E/M

Home
Issues
Browse By Topic
Conference Correspondent
- ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
- ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Association for Value-Based Cancer Care
Value-Based Care in Myeloma

Stay In The Know

Stay up to date on the matters of value in cancer by signing up for the free, bi-monthly VBCC print publication and VBCC weekly e‑newsletter.

About
About VBCC
Mission Statement
Advertising
Contact

Contribute
Submit a Manuscript
Editorial / Publishing Policies
Author Guidelines

Publications
Value-Based Cancer Care
Value-Based Care in Myeloma
Cholangiocarcinoma News

Amplity

© Amplity, Inc. All Rights Reserved. Privacy Policy.